Though some outcomes were also poorer with an interval less than a year, these were less clinically significant, experts say.

Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, has long-lasting effects on ...

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary ...

Taking place on February 14-16, 2025, in Washington, the American College of Cardiology (ACC) Advancing the Cardiovascular Care of the Oncology Patient conference is an interdisciplinary and ...

SAN DIEGO - Gossamer Bio, Inc. (NASDAQ:GOSS), a biopharmaceutical company in the clinical stage with a market capitalization of $225 million, has shared new research findings on its drug candidate ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

Front-of-package labels address this issue by simplifying key nutritional information and positioning it in a more prominent, ...

WARNING: SEVERE HYPERSENSITIVITY REACTIONS Hypersensitivity Reactions Including Anaphylaxis Patients treated with Lamzede have experienced hypersensitivity reactions, including anaphylaxis.

Eating More Fruits and Vegetables to Reduce Dietary Acid Lowers Blood Pressure and Improves Kidney and Heart Health in Patients With Hypertension Aug. 6, 2024 — Doctors recommend making fruits ...

Today, millions of Americans live with undetected hypertension, unaware that it can impact even the healthiest of individuals — a lesson that Naomi Saucer* would come to learn ...